Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Express Scripts
Boehringer Ingelheim
Merck
Baxter

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Oxaprozin - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for oxaprozin and what is the scope of patent protection?

Oxaprozin is the generic ingredient in three branded drugs marketed by Gd Searle, Actavis Elizabeth, Amneal Pharms Co, Apotex Inc, Beximco Pharms Usa, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for oxaprozin. Fourteen suppliers are listed for this compound.

Drug Prices for oxaprozin

See drug prices for oxaprozin

Drug Sales Revenue Trends for oxaprozin

See drug sales revenues for oxaprozin

Recent Clinical Trials for oxaprozin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fuji Yakuhin Co., Ltd.Phase 1
Mochida Pharmaceutical Company, Ltd.Phase 1
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all oxaprozin clinical trials

Pharmacology for oxaprozin
Synonyms for oxaprozin
.beta.-(4,5-Diphenyloxazol-2-yl)propionic acid
2-Oxazolepropanoic acid, 4,5-diphenyl-
2-Oxazolepropanoic acid,5-diphenyl-
2-OXAZOLEPROPIONIC ACID, 4,5-DIPHENYL-
2-Oxazolepropionic acid,5-diphenyl-
21256-18-8
256O188
3-(4, 5-Diphenyl-2-oxazolyl)propenoic acid
3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid
3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid #
3-(4,5-Diphenyl-2-oxazolyl)propanoic acid
3-(4,5-Diphenyl-2-oxazolyl)propenoic acid
3-(4,5-Diphenyl-2-oxazolyl)propionic acid
3-(4,5-Diphenyl-oxazol-2-yl)-propionic acid
3-(4,5-Diphenyloxazol-2-yl)propanoic acid
3-(diphenyl-1,3-oxazol-2-yl)propanoic acid
4, 5-Diphenyl-2-oxazolepropionic acid
4,5-Diphenyl-2-oxazolepropanoic acid
4,5-Diphenyl-2-oxazolepropionic acid
4,5-diphenyloxazole-2-propanoic acid
4.5-Diphenyl-2-oxazolepropanoic acid|||Daypro
A815225
AB0011812
AB00514024
AB00514024_08
AB00514024_09
AC-26512
AC1L1IK7
AC1Q759J
AC1Q759K
Actirin
AJ-08102
AKOS000206807
Alvo
ANW-63377
B1804
BCP28431
BDBM50002861
beta-(4,5-Diphenyloxazol-2-yl)propionic acid
BIDD:GT0438
BIDD:PXR0149
BPBio1_001122
BRD-K25394294-001-05-7
BRD-K25394294-001-08-1
BRN 1083168
BSPBio_001020
BSPBio_002696
C07356
C18H15NO3
CAS-21256-18-8
CCG-36508
CHEBI:7822
CHEMBL1071
CPD000058286
CS-7975
CTK7J3117
D00463
Danoprox
Daypro
Daypro (TN)
Dayrun
DB00991
Deflam
DSSTox_CID_25118
DSSTox_GSID_45118
DSSTox_RID_80684
DTXSID1045118
Durapro
Duraprost
EINECS 244-296-1
EN300-25629
EU-0100944
FT-0638104
GTPL7252
HMS1571C22
HMS1922P17
HMS2051L15
HMS2093O08
HMS2098C22
HMS3262N10
HMS3393L15
HMS3652H17
HMS3715C22
HMS566H22
HSDB 7586
HY-B0808
I14-8703
J-013955
J10396
K-6109
KB-59357
KBio3_001916
KBioGR_001722
KS-00000ULR
KS-5196
Lopac-O-9637
Lopac0_000944
LP00944
LS-100216
Maybridge1_008800
MCULE-7099031811
MFCD00215977
MHJ80W9LRB
MLS000759535
MLS001424072
MolPort-000-146-829
NC00214
NCGC00014711
NCGC00014711-01
NCGC00014711-02
NCGC00014711-03
NCGC00014711-04
NCGC00014711-05
NCGC00014711-06
NCGC00014711-07
NCGC00014711-08
NCGC00014711-09
NCGC00014711-10
NCGC00014711-11
NCGC00014711-14
NCGC00014711-15
NCGC00094249-01
NCGC00094249-02
NCGC00094249-03
NCGC00094249-04
NCGC00094249-05
NCGC00094249-06
NCGC00094249-07
NCGC00261629-01
NCI310839
NCI60_002681
NCIStruc1_000799
NCIStruc2_000787
NSC 310839
NSC-310839
NSC-758949
NSC310839
NSC758949
O 9637
O0377
OFPXSFXSNFPTHF-UHFFFAOYSA-N
Oprea1_509470
Oxapro
oxaprosin
Oxaprozi
Oxaprozin (JP17/USAN/INN)
Oxaprozin [USAN:BAN:INN:JAN]
Oxaprozin [USAN:USP:INN:BAN:JAN]
Oxaprozin, solid
Oxaprozin, United States Pharmacopeia (USP) Reference Standard
Oxaprozin,(S)
Oxaprozina
Oxaprozina [INN-Spanish]
Oxaprozine
Oxaprozine [INN-French]
Oxaprozinum
Oxaprozinum [INN-Latin]
Pharmakon1600-01505267
Prestwick0_001060
Prestwick1_001060
Prestwick2_001060
Prestwick3_001060
s4230
SAM001246770
SBB053166
SBI-0050918.P002
SC-13926
SCHEMBL3286
SMR000058286
SPBio_001652
SPBio_002940
SPECTRUM1505267
Spectrum2_001696
Spectrum3_001078
Spectrum4_001231
SR-01000076053
SR-01000076053-1
SR-01000076053-3
SR-01000076053-7
SR-01000076053-9
ST50949623
SW197319-4
TC-152122
Tox21_110059
Tox21_110059_1
Tox21_500944
UNII-MHJ80W9LRB
Voir
Walix
WY 21743
WY-21,743
WY-21743
Xopane
Z217102860
ZINC49643479

US Patents and Regulatory Information for oxaprozin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz OXAPROZIN oxaprozin TABLET;ORAL 075845-001 Jan 31, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz OXAPROZIN oxaprozin TABLET;ORAL 075850-001 Apr 27, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd OXAPROZIN oxaprozin TABLET;ORAL 075855-001 Jan 31, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Baxter
Colorcon
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.